Updates on Larynx Cancer: Risk Factors and Oncogenesis.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
18 Aug 2023
Historique:
received: 27 07 2023
revised: 14 08 2023
accepted: 15 08 2023
medline: 28 8 2023
pubmed: 26 8 2023
entrez: 26 8 2023
Statut: epublish

Résumé

Laryngeal cancer is a very common tumor in the upper aero-digestive tract. Understanding its biological mechanisms has garnered significant interest in recent years. The development of laryngeal squamous cell carcinoma (LSCC) follows a multistep process starting from precursor lesions in the epithelium. Various risk factors have been associated with laryngeal tumors, including smoking, alcohol consumption, opium use, as well as infections with HPV and EBV viruses, among others. Cancer development involves multiple steps, and genetic alterations play a crucial role. Tumor suppressor genes can be inactivated, and proto-oncogenes may become activated through mechanisms like deletions, point mutations, promoter methylation, and gene amplification. Epigenetic modifications, driven by miRNAs, have been proven to contribute to LSCC development. Despite advances in molecular medicine, there are still aspects of laryngeal cancer that remain poorly understood, and the underlying biological mechanisms have not been fully elucidated. In this narrative review, we examined the literature to analyze and summarize the main steps of carcinogenesis and the risk factors associated with laryngeal cancer.

Identifiants

pubmed: 37629093
pii: ijms241612913
doi: 10.3390/ijms241612913
pmc: PMC10454133
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Head Neck Pathol. 2014 Mar;8(1):16-23
pubmed: 24595419
Head Neck. 2009 Dec;31(12):1634-46
pubmed: 19536850
Science. 2011 Aug 26;333(6046):1154-7
pubmed: 21798897
Clin Cancer Res. 2000 Feb;6(2):347-52
pubmed: 10690509
Pathol Res Pract. 2023 Jun;246:154510
pubmed: 37167812
Int J Cancer. 1983 Aug 15;32(2):193-7
pubmed: 6307894
Eur Arch Otorhinolaryngol. 2005 Mar;262(3):170-2
pubmed: 15821906
J Transl Med. 2023 Jul 5;21(1):438
pubmed: 37408030
Head Neck. 2013 Mar;35(3):454-63
pubmed: 22907887
Arch Otolaryngol Head Neck Surg. 1995 Feb;121(2):157-60
pubmed: 7840922
Int J Cancer. 2021 Mar 1;148(5):1066-1076
pubmed: 32895947
Anticancer Drugs. 2020 Mar;31(3):260-271
pubmed: 31725046
Curr Health Sci J. 2017 Oct-Dec;43(4):367-375
pubmed: 30595905
Lancet. 2021 Dec 18;398(10318):2289-2299
pubmed: 34562395
Otolaryngol Head Neck Surg. 2016 Feb;154(2):315-21
pubmed: 26607281
Lancet. 2015 Mar 14;385(9972):966-76
pubmed: 25784347
Laryngoscope. 2018 Sep;128(9):2039-2053
pubmed: 29508408
Laryngoscope. 2016 Apr;126(4):885-93
pubmed: 26542064
Folia Med (Plovdiv). 2020 Jun 30;62(2):244-252
pubmed: 32666764
Mod Pathol. 2019 Jul;32(8):1068-1081
pubmed: 30936424
Iran J Biotechnol. 2023 Jan 01;21(1):e3339
pubmed: 36811106
Eur Rev Med Pharmacol Sci. 2018 Sep;22(17):5569-5575
pubmed: 30229830
Viruses. 2023 May 15;15(5):
pubmed: 37243256
Laryngoscope. 2019 Aug;129(8):1822-1827
pubmed: 30536822
J Surg Oncol. 2013 Nov;108(6):387-97
pubmed: 24038070
Ann Diagn Pathol. 2021 Oct;54:151787
pubmed: 34242969
Laryngoscope Investig Otolaryngol. 2020 Jan 27;5(1):74-81
pubmed: 32128433
J Clin Med. 2019 Oct 21;8(10):
pubmed: 31640140
Int J Environ Res Public Health. 2011 Apr;8(4):976-84
pubmed: 21695025
Cancer Res. 1995 Mar 1;55(5):975-8
pubmed: 7867006
Head Neck. 2016 Apr;38 Suppl 1:E2291-6
pubmed: 26316145
Int J Mol Med. 2019 Nov;44(5):1844-1854
pubmed: 31485608
Lancet Oncol. 2009 Feb;10(2):173-80
pubmed: 19185835
Nat Med. 2013 Nov;19(11):1389-400
pubmed: 24202392
J Infect Dis. 2013 Feb 1;207(3):479-88
pubmed: 23175764
Front Cell Infect Microbiol. 2019 Jul 03;9:205
pubmed: 31334130
Med Oral Patol Oral Cir Bucal. 2019 Jul 1;24(4):e444-e451
pubmed: 31256188
J Natl Cancer Inst. 2004 Jun 2;96(11):853-61
pubmed: 15173269
Arch Otolaryngol Head Neck Surg. 1996 May;122(5):497-501
pubmed: 8615966
Pathogens. 2021 Nov 04;10(11):
pubmed: 34832585
J Natl Cancer Inst. 2007 May 16;99(10):777-89
pubmed: 17505073
Nutr Rev. 2012 Aug;70 Suppl 1:S18-30
pubmed: 22861803
Chin J Cancer Res. 2020 Feb;32(1):18-25
pubmed: 32194301
J Healthc Eng. 2021 Nov 26;2021:5614861
pubmed: 34868522
Cancer Res. 1996 Jun 1;56(11):2488-92
pubmed: 8653682
Oncogene. 2007 Apr 2;26(15):2145-56
pubmed: 17401423
Alcohol Clin Exp Res (Hoboken). 2023 Jul;47(7):1238-1255
pubmed: 37422765
Clin Cancer Res. 2016 Jun 15;22(12):2939-49
pubmed: 26763254
CA Cancer J Clin. 2017 Jan;67(1):31-50
pubmed: 27898173
J Infect Dis. 2023 Jul 28;:
pubmed: 37506267
Nutrients. 2021 Sep 11;13(9):
pubmed: 34579050
Lancet Glob Health. 2020 May;8(5):e649-e660
pubmed: 32353313
Infect Agent Cancer. 2023 Jul 11;18(1):43
pubmed: 37434200
Clin Cancer Res. 1998 Jan;4(1):13-20
pubmed: 9516947
Cancer Res. 1993 Oct 1;53(19):4477-80
pubmed: 8402617
Cancer Med. 2018 May;7(5):2048-2063
pubmed: 29573243
J Laryngol Otol. 2006 Mar;120(3):170-7
pubmed: 16372991
Oral Oncol. 2020 Aug;107:104710
pubmed: 32371264
J Cancer. 2019 Jul 23;10(19):4455-4462
pubmed: 31528209
Cancer Res. 1992 Oct 1;52(19):5407-11
pubmed: 1394146
Cancer. 2003 Feb 15;97(4):1010-4
pubmed: 12569600
JAMA Oncol. 2018 Mar 01;4(3):358-365
pubmed: 29327043
Cancer Res. 1994 Jan 15;54(2):321-6
pubmed: 8275461
Diagn Pathol. 2015 Apr 03;10:22
pubmed: 25879432
J Clin Pathol. 2006 May;59(5):445-53
pubmed: 16644882
Nature. 2011 Jun 15;474(7351):327-36
pubmed: 21677749
Eur Arch Otorhinolaryngol. 2012 Apr;269(4):1073-83
pubmed: 22081098
Laryngoscope. 2009 Aug;119(8):1531-7
pubmed: 19489068
Cancer Res. 1994 Mar 1;54(5):1152-5
pubmed: 8118797
Cancer Res. 1994 Mar 1;54(5):1156-8
pubmed: 8118798
Clin Cancer Res. 2003 Aug 1;9(8):3058-64
pubmed: 12912957
Cancer Treat Rev. 2006 Nov;32(7):504-15
pubmed: 16920269
PLoS One. 2013 Jun 18;8(6):e66476
pubmed: 23824228
Oral Oncol. 2020 Jan;100:104483
pubmed: 31810040
Eur Arch Otorhinolaryngol. 2017 Jul;274(7):2921-2926
pubmed: 28439692
Clin Cancer Res. 2006 Sep 15;12(18):5268-72
pubmed: 17000658
Gut. 2012 May;61(5):646-64
pubmed: 22491499
Head Neck. 2020 Mar;42(3):539-555
pubmed: 31803979
Br J Cancer. 2015 Mar 17;112(6):1098-104
pubmed: 25688737
Hum Cell. 2023 Jan;36(1):76-97
pubmed: 36181662
Am J Med. 2006 Sep;119(9):768-76
pubmed: 16945612
Alcohol. 2005 Apr;35(3):265-75
pubmed: 16054989
Science. 2012 Oct 5;338(6103):120-3
pubmed: 22903521
Toxicol Appl Pharmacol. 1978 Nov;46(2):279-303
pubmed: 734660
Int J Biol Macromol. 2022 Dec 1;222(Pt B):1676-1687
pubmed: 36179873
J Eur Acad Dermatol Venereol. 2019 Apr;33(4):e150-e151
pubmed: 30520177
Br J Cancer. 2015 Feb 3;112(3):580-93
pubmed: 25422909
Arch Otolaryngol Head Neck Surg. 1995 Jul;121(7):790-4
pubmed: 7598859
Otolaryngol Head Neck Surg. 2012 May;146(5):730-8
pubmed: 22267491
OTO Open. 2021 Feb 25;5(1):2473974X21994743
pubmed: 34235372
J Clin Med. 2023 Jun 25;12(13):
pubmed: 37445290
Otolaryngol Head Neck Surg. 2021 Jun;164(6):1153-1159
pubmed: 33170765

Auteurs

Carlotta Liberale (C)

Unit of Otorhinolaryngology, Head & Neck Department, University of Verona, Piazzale L.A. Scuro 10, 37134 Verona, Italy.

Davide Soloperto (D)

Unit of Otorhinolaryngology, Head & Neck Department, University of Verona, Piazzale L.A. Scuro 10, 37134 Verona, Italy.

Alessandro Marchioni (A)

Respiratory Disease Unit, University Hospital of Modena, 41124 Modena, Italy.

Daniele Monzani (D)

Unit of Otorhinolaryngology, Head & Neck Department, University of Verona, Piazzale L.A. Scuro 10, 37134 Verona, Italy.

Luca Sacchetto (L)

Unit of Otorhinolaryngology, Head & Neck Department, University of Verona, Piazzale L.A. Scuro 10, 37134 Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH